Skip to main content

Table 1 Concomitant chemotherapy regimens ( n= 76)

From: Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy

Concomitant chemotherapy regimens Cycles Patients number ( n)
Vinorelbine (20 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days. 2 5
Vinorelbine (25 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days. 2 36
Docetaxel (30 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days. 2 6
Docetaxel (35 mg/m2, days 1, 8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days. 2 28
Docetaxel (40 mg/m2, days 1,8) and cisplatin (25 mg/m2, day 1,2,3), every 21 days. 2 1